AAQ1 aap Implantate AG

XETRA · DE · Healthcare · Medical Devices · aap.de
1.568USD1.430 EUR · XETRA+0.70%Mkt Cap: 23.23M USDP/E: —

aap Implantate AG develops, manufactures, and markets traumatology products for orthopedics in Germany and internationally. The company offers LOQTEQ, an anatomical plating system for the treatment of ankle, straight pla…

Key Statistics

Company
Market Cap23.23M USD
Enterprise Value26.69M USD
Revenue (TTM)13.39M USD
Gross Profit12.17M USD
Net Income (TTM)-2.84M USD
Revenue/Share0.95 USD
Last Price1.568 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees105
CountryDE
SectorHealthcare
IndustryMedical Devices
ISINDE000A3H2101
Valuation
P/E (Trailing)—
P/E (Forward)-7.15
PEG29.43
EV/EBITDA-14.96
EV/Revenue1.99
P/S1.74
P/B2.53
EPS (TTM)-0.22 USD
EPS (Forward)-0.22 USD
52W Range
1.38218% of range2.435
52W High2.435 USD
52W Low1.382 USD
Profitability
Gross Margin88.87%
Oper. Margin-22.71%
EBITDA Margin-13.33%
Profit Margin-20.70%
ROE-29.73%
ROA-18.80%
ROIC-30.61%
ROCE-25.74%
Growth
Revenue Growth-4.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.57M USD
CapEx (TTM)795.18K USD
FCF Margin-3.82%
FCF Yield-2.20%
Net Debt4.04M USD
Net Debt/EBITDA-2.27
Net Debt/FCF—
Balance Sheet
Debt/Equity0.11
Current Ratio2.07
Quick Ratio0.77
Book Value/Sh0.62 USD
Cash/Share0.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateOct 29, 2020
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.14.81M
Float5.90M
Insiders61.81%
Institutions23.06%
Technical
SMA 501.694 (-7.4%)
SMA 2001.789 (-12.3%)
Beta0.30
S&P 52W Chg12.00%
Avg Vol (30d)1.77K
Avg Vol (10d)2.56K
Technical Indicators
RSI (14)46.3
MACD-0.0333
MACD Signal-0.0400
MACD Hist.+0.0067
BB Upper1.645 USD
BB Middle1.568 USD
BB Lower1.492 USD
BB Width9.73%
ATR (14)0.0773 USD
Vol Ratio (20d)0.01x

About aap Implantate (ETR: AAQ1)

›

aap Implantate (ETR: AAQ1) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 105 employees.

The shares were at 1.430 EUR on 19 November 2026, up 0.7% over 52 weeks. Its 52-week range is 1.260 EUR to 2.220 EUR: the price is 35.6% below the high and 13.5% above the low.

Its market capitalisation is 21.18M EUR.

aap Implantate reports return on equity of -29.7%, an operating margin of -22.7% and revenue down 4.5% year over year.

Its debt exceeds its cash by 3.69M EUR, a debt-to-equity ratio of 0.11. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.